Earlier quoted context omitted.
IMO the terminology of neurochemical imbalance should be avoided. It's the sort of framing that is much preferred by the pharmacological industry, because it suggests that the nature of the problem is well understood and can be directly addressed with their products. In reality there is only a very vague idea of mental illness and related neurotransmitters. To make a computer analogy, it's like calling a problem an "…
In fairness, software runs on hardware and a faulty instruction would send electrons to the wrong place and cause an imbalance... /melvin That said, this has been proven many times over to be rooted in an atypical response to normal levels of neurotransmitters which then results in the appearance of an imbalance or, depending on your perspective, a real imbalance as that specific set of neurons requires higher baseli…
I should say I'm not at all anti-pharma. I just think that the marketing should be honest. It should be "this addresses some of the symptoms", and not "this corrects your imbalances" because the scientific hypotheses about those imbalances have long been disproven. My hunch is that the structure of neural connections also has to play a big role. This would explain why simply changing levels of chemicals does not immediately fix things.